Advocacy groups for patients with neurologic disorders have become a common feature in the landscape of drug and device development and federal research funding allocation. On Capitol Hill, advocates ...
Kathy Giusti was diagnosed with multiple myeloma in 1996, when she was a 37-year-old executive at the drug company G.D. Searle. She was told she had three years to live. Twenty-eight years later, ...
An independent nonprofit issued its twice-annual latest safety grades for hospitals around the country, and results for facilities in the South Bend region varied widely. The Leapfrog Group released ...
Ever since the US passed into law a new regulatory pathway in 2010 meant to permit the US Food and Drug Administration (FDA) to approve so-called "biosimilar products"—effectively generic biological ...
Cardiff, UK – March 9, 2026 – Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing innovative products focused on the treatment or prevention of ...
To mark World Patient Safety Day on September 17, the patient-led Light Collective plans to lead discussions in Washington, D.C., designed to help ensure that patient concerns about health data ...
Experts at the 2026 AAD Annual Meeting urged dermatologists to engage in advocacy to protect practices and patient access amid growing challenges. Klint Peebles, MD, FAAD, a dermatologist with the Mid ...
Tyra Biosciences has partnered with a patient advocacy group to create an awareness day for upper tract urothelial cancer (UTUC), a rare tumor type that its lead drug candidate targets. Working with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results